ArticleMethods in molecular biology (Clifton, N.J.)2026
Transient Expression and Characterization of Antibodies and Antibody Fragments.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter describes the cloning strategy, expression, purification, and characterization of immunoglobulin G (IgG) and corresponding antibody fragments, namely fragment antigen-binding (Fab) and single-chain variable fragment (scFv). The examples use anti-HER2 antibody, Trastuzumab, as a standard antibody. The first method details a cloning strategy that enables the easy and quick reformatting of standard human IgG1 into antibody fragments using Gibson assembly. This approach generates two plasmids that bear either light chain or heavy chain genes, under the control of the CMV promoter. The second method, and as an alternative design, presents a single vector approach carrying both light and heavy chain genes, where both genes are separated by an internal ribosome entry site (IRES). Finally, this chapter outlines the transient transfection process in Chinese hamster ovary (CHO) mammalian cells, followed by antibody purification and characterization steps for laboratory applications, highlighting key notes to achieve optimal results for IgGs, Fabs, and scFvs.
Indexed as
Identifiers
42129092What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.